2017
DOI: 10.1136/sextrans-2016-052930
|View full text |Cite
|
Sign up to set email alerts
|

A national evaluation using standardised patient actors to assess STI services in public sector clinical sentinel surveillance facilities in South Africa

Abstract: This evaluation of STI services across South Africa found gaps in the availability of medications, adherence to STI guidelines, condom provision and prevention messaging. Limited integration with HIV services for this high-risk population was a missed opportunity. Quality of STI care should continue to be monitored, and interventions to improve quality should be prioritised as part of national strategic HIV and primary healthcare agendas.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
36
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(38 citation statements)
references
References 25 publications
1
36
0
1
Order By: Relevance
“…The Chlamydia infection rate among these women is substantially higher than reported among young sexually active women from other parts of SA, including rural KwaZulu-Natal (25%) (Kleppa et al 2015) and a different area in Cape Town (15%) (Menezes et al 2017). STI management remains problematic in developing countries where laboratory-based testing is frequently unavailable and where quality of STI care may be lacking (availability of medications, adherence to STI guidelines, condom provision and partner notification counselling [Kohler et al 2017]). According to the SA Department of Health guidelines (Department of Health 2015) women qualify for STI treatment, based on a combination of demographic characteristics, symptoms or clinical observations, where STI treatment entails a combination of metronidazole, azithromycin and ceftriaxone (Peters et al 2014).…”
Section: Discussionmentioning
confidence: 94%
“…The Chlamydia infection rate among these women is substantially higher than reported among young sexually active women from other parts of SA, including rural KwaZulu-Natal (25%) (Kleppa et al 2015) and a different area in Cape Town (15%) (Menezes et al 2017). STI management remains problematic in developing countries where laboratory-based testing is frequently unavailable and where quality of STI care may be lacking (availability of medications, adherence to STI guidelines, condom provision and partner notification counselling [Kohler et al 2017]). According to the SA Department of Health guidelines (Department of Health 2015) women qualify for STI treatment, based on a combination of demographic characteristics, symptoms or clinical observations, where STI treatment entails a combination of metronidazole, azithromycin and ceftriaxone (Peters et al 2014).…”
Section: Discussionmentioning
confidence: 94%
“…The barriers to successful implementation of patient-initiated PN using referral slips were mentioned earlier in the manuscript. The concern is that South Africa has a high burden of STIs but it still relies on this strategy since the implementation of the syndromic management of STI in 2009 [27, 28].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, two-thirds had more than one sexual partners and almost half (45.6%) were in casual sexual relationships. Inaccurate information and beliefs about STIs, having multiple sexual partners and risky sexual behavior were common in male STI patients as compared to female STI patients [12, 28, 29]. This argument also has implications for reviewing the content of health education and health promotion programs in order to close the knowledge gap among the high-risk groups.…”
Section: Discussionmentioning
confidence: 99%
“…Die Chlamydia-infeksiesyfer onder hierdie vroue is aansienlik hoër as wat onder jong seksueel aktiewe vroue uit ander dele van SA gerapporteer is, insluitend die landelike streke van KwaZulu-Natal (25%) (Kleppa et al 2015) en 'n ander gebied in Kaapstad (15%) (Menezes et al 2017). Die bestuur van SOI's bly problematies in ontwikkelende lande waar laboratoriumgebaseerde toetse dikwels nie beskikbaar is nie en waar die kwaliteit van SOI-versorging tekortskiet (in terme van beskikbaarheid van medisyne, nakoming van SOI-riglyne, kondoomvoorsiening en MIV-berading [Kohler et al 2017]). Volgens die SA Departement van Gesondheid se riglyne (Department of Health 2015), kwalifiseer vroue vir SOIbehandeling gebaseer op 'n kombinasie van demografiese eienskappe, simptome en/of kliniese waarnemings, waar SOI-behandeling 'n kombinasie metronidazole, azithromycin en ceftriaxone behels (Peters et al 2014).…”
Section: Soi-voorkomssyfers (55%)unclassified